Uppsala, Switzerland

Emplicure Ab


USPTO Granted Patents = 8

% Expired Patents = 25.0



Forward Citations = 5

Loading Chart...
Loading Chart...

7 inventors (with patents filed for the assignee):

goldMedal Håkan Engqvist (8 out of 29 patents)

silverMedal Susanne Bredenberg (4 out of 6 patents)

bronzeMedal Anna Dahlgren (4 out of 4 patents)

4.  Anders Sågström (4 out of 4 patents)

5.  Thomas Lundqvist (2 out of 4 patents)

6.  Anders Petterson (1 out of 1 patent)

7.  Anders Pettersson (1 out of 23 patents)

8.  Wei Xia (4 patents)

9.  Jesper Lööf (3 patents)

10.  Håkan Engqvist (5 patents)

11.  Anders Pettersson (0 patent)

12.  Thomas Lundqvist (0 patent)

13.  Anders Sagstrom (0 patent)

14.  Anders Saegstroem (0 patent)

15.  Haekan Engqvist (0 patent)


8 patents:

Company Overview
Emplicure Ab is a biotechnology company focused on developing novel therapies for chronic inflammatory diseases. The company's innovative approach targets specific pathways to modulate the immune response and reduce inflammation. Emplicure's pipeline includes potential treatments for conditions such as rheumatoid arthritis, inflammatory bowel disease, and psoriasis. By harnessing the power of the immune system, Emplicure aims to improve the lives of patients suffering from these debilitating diseases.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

8 Patents

#1 in Uppsala

#1,307 in Switzerland

Uppsala, CH
Uppsala, Switzerland
Forward Citations = 5

7 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Emplicure Ab. Retrieved from https://idiyas.com/company/emplicure-ab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…